68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy?

CONCLUSION: In patients with intermediate/high-risk prostate cancer, 68Ga-PSMA PET/CT provides information regarding intraprostatic tumor location, SVI and LNI but has no role in assessment for EPE. This information might be useful for pretreatment counseling, decision-making and possibly preoperative planning.
PMID: 31204017 [PubMed - as supplied by publisher]

Source: Urologic Oncology - June 12, 2019 Category: Urology & Nephrology Authors: Dekalo S, Kuten J, Mabjeesh NJ, Beri A, Even-Sapir E, Yossepowitch O Tags: Urol Oncol Source Type: research